1. 022 Updated safety of cladribine tablets in multiple sclerosis patients: integrated safety analysis and post-approval data. Issue 6 (27th May 2022) Authors: Cook, Stuart; Giovannoni, Gavin; Leist, Thomas; Comi, Giancarlo; Syed, Sana; Nolting, Axel; Damian, Doris; Schick, Regina; Jack, Dominic Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 040 An analysis of malignancy risk in the clinical development programme of cladribine tablets in patients with relapsing multiple sclerosis. Issue 6 (24th May 2018) Authors: Galazka, Andrew; Nolting, Axel; Cook, Stuart; Leist, Thomas; Comi, Giancarlo; Montalban, Xavier; Hicking, Christine; King, John; Dangond, Fernando Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 6(2018) Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 088 Cladribine tablets were associated with rapid onset of improvements in MRI outcomes in the ORACLE-MS trial. (29th July 2019) Authors: Gillett, Alan; Scarberry, Susan; Damian, Doris; Hyvert, Yann; Dangond, Fernando; Lebson, Lori; Leist, Thomas Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90(2019)e7 Page Start: A28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 090 The effect of cladribine tablets on delaying the time to conversion to clinically definite multiple sclerosis (MS) or McDonald MS is consistent across subgroups in the ORACLE-MS study. (29th July 2019) Authors: Bowen, James; Gillett, Alan; Damian, Doris; Hyvert, Yann; Dangond, Fernando; Grosso, Megan; Leist, Thomas Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90(2019)e7 Page Start: A29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Analysis of frequency and severity of relapses in multiple sclerosis patients treated with cladribine tablets or placebo: The CLARITY and CLARITY Extension studies. (January 2022) Authors: De Stefano, Nicola; Sormani, Maria Pia; Giovannoni, Gavin; Rammohan, Kottil; Leist, Thomas; Coyle, Patricia K; Dangond, Fernando; Keller, Birgit; Alexandri, Nektaria; Galazka, Andrew Journal: Multiple sclerosis Issue: Volume 28:Number 1(2022) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cladribine tablets added to IFN-β in active relapsing MS: The ONWARD study. Issue 5 (September 2018) Authors: Montalban, Xavier; Leist, Thomas P.; Cohen, Bruce A.; Moses, Harold; Campbell, Jackie; Hicking, Christine; Dangond, Fernando; Comi, Giancarlo; Gallo, Paolo; Pozzilli, Carlo; Gasperini, Claudio; Morra, Vincenzo Brescia; Boyko, Alexey N; Amelina, Olga; Kotov, Sergey V; Novikova, Lilia; Patrusheva, ... Journal: Neurology Issue: Volume 5:Issue 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022) Authors: Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu... Journal: Lancet neurology Issue: Volume 21:Issue 7(2022) Page Start: 608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers. (June 2019) Authors: Stuve, Olaf; Soelberg Soerensen, Per; Leist, Thomas; Giovannoni, Gavin; Hyvert, Yann; Damian, Doris; Dangond, Fernando; Boschert, Ursula Journal: Therapeutic advances in neurological disorders Issue: Volume 12(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Long-term follow-up of patients with relapsing multiple sclerosis from the CLARITY/CLARITY Extension cohort of CLASSIC-MS: An ambispective study. (May 2023) Authors: Giovannoni, Gavin; Boyko, Alexey; Correale, Jorge; Edan, Gilles; Freedman, Mark S; Montalban, Xavier; Rammohan, Kottil; Stefoski, Dusan; Yamout, Bassem; Leist, Thomas; Aydemir, Aida; Borsi, Laszlo; Verdun di Cantogno, Elisabetta Journal: Multiple sclerosis Issue: Volume 29:Number 6(2023) Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO139 Integrated safety analysis; cladribine in multiple sclerosis (ms). (1st December 2017) Authors: Cook, Stuart; Leist, Thomas; Comi, Giancarlo; Montalban, Xavier; Sylvester, Elke; Hicking, Christine; Dangond, Fernando Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88(2017)Supplement 1 Page Start: A49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗